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Transcription Factor FIGLA is Mutated in Patients
with Premature Ovarian Failure
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Premature Ovarian Failure (POF) is a genetically heterogenous disorder that leads to hypergonadotropic ovarian failure and infertility.
We screened 100 Chinese womenwith POF formutations in the oocyte-speciﬁc gene FIGLA and identiﬁed three variants in four women:
missense mutation c.11C/ A (p.A4E) was found in two women; deletion c. 15–36 del (p.G6fsX66), resulting in a frameshift that leads
to haploinsufﬁciency, was found in one woman; and deletion c.419–421 delACA (p.140 delN) was found in one. Functional analyses by
the yeast two-hybrid assay demonstrated that the p.140 delN mutation disrupted FIGLA binding to the TCF3 helix-loop-helix (HLH)
domain. Our ﬁndings show that a subset of Chinese women with sporadic, premature ovarian failure harbor mutations in FIGLA.Premature Ovarian Failure (POF [MIM 311360]) is deﬁned
as a primary ovarian defect characterized by premature de-
pletion of ovarian follicles before the age of 40 years.1 POF
has an estimated prevalence of one in 10,000womenby age
20, one in 1000 women by age 30, and one in 100 women
by age 40.2 Premature ovarian failure can be heritable, but
few mechanisms have been identiﬁed.3–5 Known nonge-
netic mechanisms include gonadotoxic chemotherapy,
radiation treatment, and autoimmune oophoritis, but in
most cases POF is idiopathic and probably genetic.6 Besides
chromosome abnormalities involving X or autosomes,7
single-gene-mutation associations with POF include fragile
Xmental retardation 1 (FMR1 [MIM 309550]),8–12 forkhead
box L2 (FOXL2[MIM 605597]),13–15 premature ovarian
failure 1B (POF1B [MIM 300603]),16,17 inhibin alpha
(INHA [MIM 147380]),18–23 NOBOX oogenesis homeobox
(NOBOX [MIM 610934],24 growth differentiation factor 9
(GDF9 [MIM 601918]), and bone morphogenetic protein
15 (BMP15 [MIM 300247]).25–30 FMR1 premutation carriers
have a 15% risk of developing POF, whereas the prevalence
of FMR1 premutation among women with sporadic POF is
less than 10%.31 The prevalence of other gene mutations
in women with POF is not well known. Mouse models32–37
of ovarian failure closely mimic human ovarian failure,
as exempliﬁed by mutations in the human and mouse
follicle-stimulating hormone (FSH) receptor (FSHR [MIM
136435]).32–35 Targeted deletion of mouse genes indicates
that there aremore than 200 genes that can cause reproduc-
tive dysfunction.38
Factor in germline alpha (FIGLA [MIM 608697]), located
on human chromosome 2p13.3, is a germ cell-speciﬁc
basic helix-loop-helix (bHLH) transcription factor that
regulates expression of zona pellucida genes as well as
that of other oocyte-speciﬁc genes.37,39,40 bHLH proteins
are a group of highly conserved transcription factors that
typically bind to a consensus sequence (CANNTG), called1342 The American Journal of Human Genetics 82, 1342–1348, Junean E-box, to promote selective genes.41,42 In both mouse
and human, FIGLA is expressed in the embryonic gonad,
heterodimerizes with ubiquitously expressed bHLH pro-
tein TCF3 (transcription factor 3 [MIM 147141]), and binds
to the zona pellucida gene promoters.37,40 Figla knockout
mice cannot form primordial follicles and lose oocytes
rapidly after birth, whereas male gonads are unaffected.36
The ovarian-failure phenotype in mice makes FIGLA a can-
didate gene for premature ovarian failure in humans. We
therefore examined whether mutations in FIGLA are pres-
ent in women with premature ovarian failure, speciﬁcally
a Han Chinese cohort, compared with an ethnically
matched control cohort.
In this study, 100 Chinese women with POF were re-
cruited from the Reproductive Medical Center, Shandong
Provincial Hospital Afﬁliated to Shandong University in
Jinan, Shandong, China. Controls were healthy women
chosen randomly between 30 and 62 years of age, with reg-
ular menstrual cycles and no known history of infertility.
Institutional review boards at both Shandong Provincial
Hospital and Baylor College of Medicine approved the
study. Written informed consent was obtained from all
participants. Inclusion criteria were deﬁned as cessation of
menstrual cycles before 40 years of age,43 two serum FSH
concentrations greater than 40 IU/L, and normal 46, XX
karyotype. Women with associated endocrinopathies or
autoimmune disorders were also excluded.
Genomic DNA was extracted from blood samples, and
the ﬁve exons coding for FIGLA (GeneBank accession
number NM_001004311) were ampliﬁed with polymerase
chain reaction (PCR) with four pairs of FIGLA-speciﬁc
primers (Table S1, available online). Sequencing was per-
formed via ABI Prism Sequencer 3130XL (Applied Biosys-
tems) as previously described.44 The PCR products were
sequenced with BigDye Sequencing reagent V3.1 (Applied
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with the use of Performa Ultra 96-well PCR plates (Edge
Biosystems). Sequence analyses were performed with
Sequencher 4.2 software (Gene Codes).
Among the 100 Chinese POF subjects, we identiﬁed in
the FIGLA gene two single-nucleotide polymorphisms
(SNPs), c.422C / G and c.552A / C, in both controls
and POF subjects. These polymorphisms have already
been reported in the online dbSNP database (dbSNP acces-
sion numbers rs7566476 and rs7566541, respectively) and
did not show a statistically signiﬁcant difference between
controls and women with POF. We also detected three
novel heterozygous variants in four individuals (Table 1):
c.11C/ A (p.A4E), c.15–36 del (p. G6fsX66), and c.419–
421 del ACA (p.140 delN), which have been deposited
into the dbSNP database. The c.11C/ A changes alanine
for glutamic acid and was present in two individuals with
POF (S8 and S58; details are provided in Table 2) but was
also present in one of the 304 control subjects. The
c.11C/ A thus probably represents a rare polymorphism.
However, c.15–36 del and c.419–421 delACA mutations
were detected only in women with POF and in none of
the 304 controls.
The 22 base pair (22 bp) deletion, c.15–36 del
(p.G6fsX66) in case S13 (Figure 1), is predicted to cause
a frame shift at the 6th codon and change glycine to argi-
nine to create a new open-reading frame ending in a stop
codon at position 66 (G6fsX66).This effectively creates
FIGLA haploinsufﬁciency. wild-type (WT) FIGLA encodes
219 amino acids, whereas truncated FIGLA protein shares











ss99307022 1 c.11C/ A p.Ala4Glu 2/100 1/304
ss99307023 1 c. 15–36 del p.G6fsX66 1/100 0/304
rs7566476 3 c.422C/ G p.Ser141Thr 12/100 35/304
rs7566541 3 c.552A/ G Silent 12/100 35/304
ss99307024 3 c.419–21 delACA p.140 delAsn 1/100 0/304
POF ¼ Premature Ovarian Failure; FIGLA ¼ Factor in the Germline alpha.The Amonly a ﬁve-amino-acid homology with the wild-type. The
c.15–36 delta was not found among the entire 304 control
cohort. The deleted nucleic acids are ﬂanked by identical
nine-nucleotide-long repeats (CCCCGCGCC).We hypoth-
esize that misalignment between the ﬁrst and the second
repeat during recombination causes the 22bp deletion.
S13 presented with secondary amenorrhea at 36 years of
age (Table2).Menarcheoccurredwhenshewas14years old,
and her subsequent menstrual cycles were irregular. At 23
years of age, she gave birth to a girl who is now healthy at
the ageof 16years. S13presentedwithhotﬂashes, excessive
sweating, lassitude, emotional lability, and vaginal dryness.
Her initial FSH concentration was 48.1 IU/L, and a subse-
quent concentrationwas 50.6 IU/L. Pelvic ultrasonography
showed a small uterus (55335330mm) and bilateral-streak
ovaries devoid of follicles. The proband’s 15–36 del muta-
tion was inherited from her father, who has no evident so-
matic anomalies. S13’s mother and daughter do not carry
the deletion and have no reproductive or menstrual
dysfunction.
The c.419–421 delACA variant (p.140 delN) causes a loss
in asparagine at position 140 (Figure 2). The proband (S69)
was a 29-year-old woman presenting with secondary
amenorrhea and infertility. Menarche occurred when she
was 14 years old, and menstrual cycles were normal until
27 years of age, at which time secondary amenorrhea
ensued. FSH concentrations were highly elevated on
two separate interval measurements, at 70.4IU/L and
89.6IU/L, respectively. Transvaginal ultrasonography
showed a small uterus (453 35 mm), an atrophic endome-
trium, and a small right ovary (12 3 10 mm) devoid of fol-
licles. The left ovary was not visualized. She had no other
medical problems and lacked dysmorphic features. Her
parents are healthy; no other family members had POF.
FIGLA is known to heterodimerize with TCF3.37, 40 We
tested whether the missense or deleted (c.11C / A or
c.419–421 delACA) alleles affect the ability of FIGLA to
dimerize with itself or TCF3 by utilizing a yeast two-hybrid
strategy to study protein-protein interactions. Proteins un-
der study were either fused to GAL4 DNA-binding domain
as a bait or fused to GAL4-activation domain as a prey. IfTable 2. Phenotype of Women with POF Carrying FIGLA Mutations
Patient Variant Age* (yrs) Karyotype FSH (IU/L) LH (IU/L) E2 (pg/ml) Additional Information
S8 p.Ala4Glu 22 46,XX 70.0a; 78.5b 19.5a; 24.7b 44.2a; 31.8b Perimenopausal syndrome; TV-B: Streak
left ovary; right ovary not visualized
S13 p.G6fsX66 36 46,XX 48.1a; 50.6b 32.1a; 11.5b 28.0a; 22.0b Perimenopausal syndrome; TV-B:
Ovaries not visualized
S58 p.Ala4Glu 32 46,XX 95.7a; 135.7b 42.9a; 47.1b 42.0a; 27.3b TV-B: Small uterus and bilateral streak
ovaries
S69 p.140 delAsn 27 46,XX 70.4a; 89.6b 28.8a; 45.2b 17.0a; 11.2b TV-B: Small uterus and small right ovary
devoid of follicles; left ovary not visualized
FIGLA denotes factor in the germline alpha; FSH denotes follicle-stimulating hormone; LH denotes luteinizing hormone; E2 denotes estradiol; TV-B denotes
Transvaginal ultrasonography.
* Age at exposure.
a Serum levels; initial value.
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bait and prey interact physically when brought together in
a yeast reporter strain, GAL4 promoter-driven reporter
genes (LacZ, ADE2, HIS3, and MEL1) will be transcribed,
thus resulting in blue colonies on synthetic droupout (SD)
plates selective for Ade, His, Leu, Trp, and X-a-gal
(Figure 3A). In this study, full-length wild-type human
FIGLA cDNA was purchased from ATCC (Manassas, VA,
USA), and TCF3 cDNAwas a gift from Rosemary A.L. Bayne
(Centre for Reproductive Biology, University of Edinburgh,
Edinburgh, UK40). FIGLA and TCF3 (Ensembl accession
number ENSG00000071564) constructs were subcloned
into the MatchMaker GAL4 two-hybrid pGBKT7 and
pGADT7 vectors (Clontech), and primer sequences are
shown in Table S1.
Mutant constructs carrying c.11C / A and c.419–421
delACA were created with the Quik-Change multi-site-
directed mutagenesis kit (Stratagene) according to the
manufacturer’s instructions.
We studied protein-protein interactions by transforming
the Y187 yeast strain with mutant (11C/ A and 419–421
del) and wild-type FIGLA constructs subcloned into the
bait vector (pGBKT7) as previously described.44 The corre-
Figure 1. FIGLA Mutation c.15–36 del
(G6fsX66)
(A) Partial nucleotide sequences of the
mutant and WT alleles are shown on top
and bottom of the sequence, respectively.
(B) The 22 bp deletion (dashed box) causes
a frame shift beginning at the 6th codon
and creates a new open reading frame
(red boxes). The deletion is flanked by
two identical nine-nucleotide sequences
(CCCCGCGCC) (blue shade).
Figure 2. FIGLA Mutation c.419–421 del ACA (p.140 delN)
(A) The mutant-allele partial sequence is shown in red, and the
WT-allele partial sequence is shown in black on the top and the
bottom of the sequence chromatogram, respectively.
(B) Human FIGLA gene is schematically drawn with five known
exons (gray boxes). The three deleted nucleotides ACA are lo-
cated in the FIGLA exon3 and cause a loss in asparagine at po-
sition 140, which is downstream of the FLGLA HLH domain
(green rhombus).
sponding prey (pGADT7) vectors con-
taining wild-type FIGLA, FIGLA HLH
domain, or TCF3 HLH domain were
transformed into the AH109 yeast
strain. Y187 and AH109 cells trans-
formed with the bait and prey con-
structs were selected on SD plates lacking either tryptophan
(SD/Trp) or leucine (SD/Leu), respectively, and the
two strains were mated according to the manufacturer’s
instructions. Mating mixtures were spread onto double-
dropout plates (SD[Leu/Trp]) for the growing of diploids.
Diploid strains were streaked onto quadruple-dropout
plates (SD[Ade/His/Leu/Trp/X-a-gal]), and positive
interactions scored as blue colonies. Each experiment was
performed in three replicates. In this study, SV40 T antigen
withp53andSV40TantigenwithLaminCwereusedaspos-
itive and negative controls, respectively.
We mated human wild-type FIGLA with itself or with
TCF3 HLH domain containing prey constructs. Blue colo-
nies grew on selective plates only by the mating of yeast
bait wild-type (WT) FIGLA (full-length or HLH domain)
with prey TCF3 HLH domain, indicating that human
FIGLA can heterodimerize with TCF3 HLH domain but
does not homodimerize with itself. We also studied
whether TCF3 HLH domain can interact with FIGLA mu-
tant proteins A4E and 140 delN. As shown in Figure 3B,
blue colonies were detected within three days when TCF3
HLH domain was mated with WT FIGLA or FIGLA mutant1344 The American Journal of Human Genetics 82, 1342–1348, June 2008
Figure 3. Dimerization of WT and Mu-
tant FIGLA with the TCF3 HLH Domain
in Yeast Two-Hybrid Assay
(A) Diagram of the system used in the yeast
two-hybrid assay. FIGLA fusion to the GAL4
DNA-binding domain (FIGLA-BD) will drive
transcription of reporter genes only if it in-
teracts with TCF3 HLH fused to the GAL4-
activation domain (TCF3 HLH-AD). HLH de-
notes helix-loop-helix domain.
(B and C) Mating strains were streaked
onto SD plates selective for Ade, His,
Leu, Trp, and X-a-gal and incubated
for three days. Positive protein-protein
interactions allow the transcription of re-
porter genes that permit mating strains
to grow on selective media and appear as
blue colonies (B). The mating of FIGLA
HLH mutant 140N to the TCF3 HLH domain
carrying yeast did not yield blue colonies
([B], sector 4), despite the presence of
an equivalent amount of mutant HLH 140
delN protein in the yeast (C).
(D) A BioSensor fluorometric assay was per-
formed to confirm interactions observed
in (B). Bait-and-prey combination is shown
below the corresponding bar. After 32 hr of
culturing, fluorescence intensity increased
more than 50-fold with colonies containing
WT FIGLA and mutant A4E. However, yeast
colonies containing the mutant 140 delN
protein (lane 4) failed to show increase in
fluorescence, suggesting little interaction
with TCF3 HLH. Fluorescence was normal-
ized to the baseline at time zero (0 hr).
Values are expressed as mean þ SEM (N ¼
3). Bars with different superscript letters
(a and b) are significantly different (p <
0.001; one-way ANOVA).A4E, but only a few white colonies appeared when it was
mated with FIGLA HLH mutant 140 delN despite equiva-
lent amounts ofmutant andWT FIGLA protein (Figure 3C).
We veriﬁed the two-hybrid interactions with an oxygen-
biosensor assay. In three independent experiments, we
measured the ﬂuorescence emitted by the O2-sensing plat-
form that detectsGAL4. The amount of ﬂuorescence inten-
sity increases according to the strength of the two-hybrid
interactions.45 With this method used, TCF3 HLH domain
showed strong interaction with the WT FIGLA, as well as
with mutant FIGLA A4E protein. Mutant FIGLA 140 delN
protein showed markedly decreased interaction with
the TCF3 HLH domain (p < 0.001; ANOVA) (Figure 3D).
The data imply that the mutant protein FIGLA140 delN
disrupts heterodimer formation between FIGLA and
TCF3 whereas A4E missense mutation does not have
appreciable effect on the FIGLA and TCF3 interaction
in vitro.
In this study,we identiﬁed twoplausiblemutations in the
FIGLA gene among 100 POF cases (2%), whereas none wereThe Ampresent among 304 ethnically matched controls. FIGLA is
a germ cell-speciﬁc transcription factor preferentially ex-
pressed in oocytes and critical in oocyte differentiation.
Transgenic mouse models replicate known human repro-
ductive phenotypes well, as exempliﬁed by FSH-receptor
mutations.32–35 Mice completely lacking Figla expression
lose oocytes rapidly after birth, are infertile, and do not dis-
play any other anatomic abnormality or dysmorphology.36
These mice thus represent a good model for the study of
nonsyndromic ovarian failure. Our results, as well as sup-
porting data from studies performed with mice, indicate
that FIGLA mutations contribute to human POF. Given
the heterozygous nature of mutations we report here, we
cannot rule out the possibility that other genes and/or
environmental factors modulate the effects of these muta-
tions on ovarian function.
One of the two heterozygous mutations we detected,
G6fsX66, is predicted to prematurely terminate translation
of the FIGLA transcript after ﬁve amino acids. Transcrip-
tion-factor haploinsufﬁciency is a well-recognized causeerican Journal of Human Genetics 82, 1342–1348, June 2008 1345
of many human genetic syndromes.46 Most mice heterozy-
gous for transcription-factor mutations have no discern-
able phenotype, and only a homozygous transcription-
factor mutation leads to pathology in mice.46 Detailed
characterization of oocyte numbers in adult Figla mice is
lacking, but given what is known about other mouse
models of transcription-factor insufﬁciency, we postulate
that FIGLA haploinsufﬁciency in humans causes prema-
ture ovarian failure by disrupting formation of primordial
follicles, as observed in Figla mouse knockouts, resulting
in diminished follicular endowment and accelerated oo-
cyte loss throughout the reproductive lifespan. We cannot
exclude the possibility that the new protein created by the
G6fsX66 mutation adversely affects WT FIGLA function
via dominant negative interaction.
The 140 delN mutation was also not present in the con-
trol cohort of women, and yeast two-hybrid analysis shows
adverse effects of this mutation on FIGLA interaction with
TCF3. Abnormal FIGLA function could be due to domi-
nant negative interference of the 140 delN protein on
the binding of WT FIGLA to TCF3, or it could be due to de-
creased levels of functional heterodimers.44 The interac-
tion between TCF3 and other bHLH transcription regula-
tors occurs mainly via the bHLH domain; however, our
study shows that residues outside of the bHLH domain
are also important for the interaction of FIGLA with
TCF3. The deleted asparagine is carboxy terminal to the
bHLH domain. Residues carboxy terminal to the bHLH
domain have been shown to affect heterodimerization.47
To our knowledge, this is the ﬁrst study to evaluate mu-
tations in the FIGLA gene in women with premature ovar-
ian failure. We identiﬁed two plausible mutations in FIGLA
among 100 Chinese POF subjects. Our study shows that
FIGLA mutations contribute to the pathophysiology of
ovarian failure and adds to the growing evidence that dis-
ruption of germ cell-speciﬁc pathways adversely affects
oocyte survival in humans. Future studies should focus
comprehensively on germ cell-speciﬁc pathways as con-
tributors to the etiology of POF.
Supplemental Data
One supplemental table is available with this manuscript online at
http://www.ajhg.org/.
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